BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Metawi SA, Abbas D, Kamal MM, Ibrahim MK. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol. 2011;30:1201-1207. [PMID: 21874405 DOI: 10.1007/s10067-011-1737-y] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Benedetti G, Miossec P. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. Eur J Immunol 2014;44:339-47. [PMID: 24310226 DOI: 10.1002/eji.201344184] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 13.4] [Reference Citation Analysis]
2 Chen S, Blijdorp IC, van Mens LJJ, Bowcutt R, Latuhihin TE, van de Sande MGH, Shaw S, Yeremenko NG, Baeten DLP. Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis. J Rheumatol 2020;47:1606-13. [PMID: 31941804 DOI: 10.3899/jrheum.190571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Shen H, Huo Z, Bai Y, He X, Li C, Zhao Y, Guo Q. Protective Effect of Norcantharidin on Collagen-Induced Arthritis Rats. Chin J Integr Med 2018;24:278-83. [DOI: 10.1007/s11655-017-2792-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
4 Tykocinski L, Lauffer AM, Bohnen A, Kaul N, Krienke S, Tretter T, Adam I, Mohapatra SR, Saikali P, Löhning M, Neidhart M, Gay S, Oezen I, Platten M, Opitz CA, Lorenz H. Synovial Fibroblasts Selectively Suppress Th1 Cell Responses through IDO1-Mediated Tryptophan Catabolism. J I 2017;198:3109-17. [DOI: 10.4049/jimmunol.1600600] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
5 Bakheet SA, Ansari MA, Nadeem A, Attia SM, Alhoshani AR, Gul G, Al-Qahtani QH, Albekairi NA, Ibrahim KE, Ahmad SF. CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance. Cell Signal 2019;64:109395. [PMID: 31449849 DOI: 10.1016/j.cellsig.2019.109395] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
6 Du Y, Tong Y, Mei W, Jia J, Niu M, Cao W, Lou W, Li S, Li Z, Stinson WA, Yuan H, Zhao W. A Truncated IL-17RC Peptide Ameliorates Synovitis and Bone Destruction of Arthritic Mice. Adv Healthcare Mater 2016;5:2911-21. [DOI: 10.1002/adhm.201600668] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
7 Konya C, Paz Z, Apostolidis SA, Tsokos GC. Update on the role of Interleukin 17 in rheumatologic autoimmune diseases. Cytokine 2015;75:207-15. [PMID: 26028353 DOI: 10.1016/j.cyto.2015.01.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
8 Castro-sánchez P, Roda-navarro P. Physiology and Pathology of Autoimmune Diseases: Role of CD4+ T cells in Rheumatoid Arthritis. In: Rezaei N, editor. Physiology and Pathology of Immunology. InTech; 2017. [DOI: 10.5772/intechopen.70239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Vijatov-Djuric G, Doronjski A, Mitic I, Brkic S, Barisic N. Interleukin-17A Levels Increase in Serum of Children With Juvenile Idiopathic Arthritis. Arch Rheumatol 2017;32:234-43. [PMID: 30375522 DOI: 10.5606/ArchRheumatol.2017.6067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Olewicz-gawlik A, Danczak-pazdrowska A, Kuznar-kaminska B, Gornowicz-porowska J, Katulska K, Trzybulska D, Batura-gabryel H, Silny W, Poplawski D, Hrycaj P. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis. Int J Rheum Dis 2014;17:664-70. [DOI: 10.1111/1756-185x.12290] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
11 Moise N, Friedman A. Rheumatoid arthritis - a mathematical model. Journal of Theoretical Biology 2019;461:17-33. [DOI: 10.1016/j.jtbi.2018.10.039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
12 Gullick NJ, Abozaid HS, Jayaraj DM, Evans HG, Scott DL, Choy EH, Taams LS. Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritis. Clin Exp Immunol 2013;174:292-301. [PMID: 23815507 DOI: 10.1111/cei.12167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lee SY, Cho ML, Oh HJ, Ryu JG, Park MJ, Jhun JY, Park MK, Stone JC, Ju JH, Hwang SY, Park SH, Surh CD, Kim HY. Interleukin-2/anti-interleukin-2 monoclonal antibody immune complex suppresses collagen-induced arthritis in mice by fortifying interleukin-2/STAT5 signalling pathways. Immunology 2012;137:305-16. [PMID: 23167249 DOI: 10.1111/imm.12008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
14 Ma Z, Wang B, Wang M, Sun X, Tang Y, Li M, Li F, Li X. TL1A increased IL-6 production on fibroblast-like synoviocytes by preferentially activating TNF receptor 2 in rheumatoid arthritis. Cytokine 2016;83:92-8. [PMID: 27081759 DOI: 10.1016/j.cyto.2016.04.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
15 Perng OA, Aitken M, Rankin AL, Garcia V, Kropf E, Erikson J, Garlick DS, Caton AJ. The degree of CD4+ T cell autoreactivity determines cellular pathways underlying inflammatory arthritis. J Immunol 2014;192:3043-56. [PMID: 24591372 DOI: 10.4049/jimmunol.1302528] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
16 Kim B, Park Y, Chung Y. Targeting IL-17 in autoimmunity and inflammation. Arch Pharm Res 2016;39:1537-47. [DOI: 10.1007/s12272-016-0823-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
17 Wehmeyer C, Pap T, Buckley CD, Naylor AJ. The role of stromal cells in inflammatory bone loss. Clin Exp Immunol 2017;189:1-11. [PMID: 28419440 DOI: 10.1111/cei.12979] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
18 Chen K, Kolls JK. Interluekin-17A (IL17A). Gene 2017;614:8-14. [PMID: 28122268 DOI: 10.1016/j.gene.2017.01.016] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 15.5] [Reference Citation Analysis]
19 Tabarkiewicz J, Pogoda K, Karczmarczyk A, Pozarowski P, Giannopoulos K. The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases. Arch Immunol Ther Exp (Warsz) 2015;63:435-49. [PMID: 26062902 DOI: 10.1007/s00005-015-0344-z] [Cited by in Crossref: 116] [Cited by in F6Publishing: 94] [Article Influence: 19.3] [Reference Citation Analysis]
20 van den Berg WB, McInnes IB. Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics. Semin Arthritis Rheum 2013;43:158-70. [PMID: 24157091 DOI: 10.1016/j.semarthrit.2013.04.006] [Cited by in Crossref: 96] [Cited by in F6Publishing: 80] [Article Influence: 13.7] [Reference Citation Analysis]
21 Kharwar N, Prasad K, Singh K, Paliwal V, Modi D. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain–Barré syndrome. International Journal of Neuroscience 2016;127:680-7. [DOI: 10.1080/00207454.2016.1231186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
22 Fu Y, Liu S, Wang Y, Ren F, Fan X, Liang J, Liu C, Li J, Ju Y, Chang Z. GdX/UBL4A‐knockout mice resist collagen‐induced arthritis by balancing the population of T h 1/T h 17 and regulatory T cells. FASEB j 2019;33:8375-85. [DOI: 10.1096/fj.201802217rr] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Abdalmula A, Dooley LM, Kaufman C, Washington EA, House JV, Blacklaws BA, Ghosh P, Itescu S, Bailey SR, Kimpton WG. Immunoselected STRO-3+ mesenchymal precursor cells reduce inflammation and improve clinical outcomes in a large animal model of monoarthritis. Stem Cell Res Ther 2017;8:22. [PMID: 28173831 DOI: 10.1186/s13287-016-0460-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
24 Zhu M, Xu Q, Li XL, He Q, Wang WF. Modulating effects of leflunomide on the balance of Th17/Treg cells in collageninduced arthritis DBA/1 mice. Cent Eur J Immunol 2014;39:152-8. [PMID: 26155116 DOI: 10.5114/ceji.2014.43714] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Sarkar S, Justa S, Brucks M, Endres J, Fox DA, Zhou X, Alnaimat F, Whitaker B, Wheeler JC, Jones BH, Bommireddy SR. Interleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis. Clin Exp Immunol 2014;177:652-61. [PMID: 24813051 DOI: 10.1111/cei.12376] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
26 Eyerich K, Dimartino V, Cavani A. IL-17 and IL-22 in immunity: Driving protection and pathology. Eur J Immunol 2017;47:607-14. [PMID: 28295238 DOI: 10.1002/eji.201646723] [Cited by in Crossref: 146] [Cited by in F6Publishing: 140] [Article Influence: 36.5] [Reference Citation Analysis]
27 Hattori T, Ogura N, Akutsu M, Kawashima M, Watanabe S, Ito K, Kondoh T. Gene Expression Profiling of IL-17A-Treated Synovial Fibroblasts from the Human Temporomandibular Joint. Mediators Inflamm 2015;2015:436067. [PMID: 26839464 DOI: 10.1155/2015/436067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
28 Li S, Yu M, Li H, Zhang H, Jiang Y. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome. Mediators Inflamm 2012;2012:260473. [PMID: 23091305 DOI: 10.1155/2012/260473] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
29 Basdeo SA, Moran B, Cluxton D, Canavan M, McCormick J, Connolly M, Orr C, Mills KH, Veale DJ, Fearon U, Fletcher JM. Polyfunctional, Pathogenic CD161+ Th17 Lineage Cells Are Resistant to Regulatory T Cell-Mediated Suppression in the Context of Autoimmunity. J Immunol 2015;195:528-40. [PMID: 26062995 DOI: 10.4049/jimmunol.1402990] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 8.2] [Reference Citation Analysis]
30 Furst DE, Emery P. Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology (Oxford) 2014;53:1560-9. [PMID: 24402580 DOI: 10.1093/rheumatology/ket414] [Cited by in Crossref: 118] [Cited by in F6Publishing: 104] [Article Influence: 16.9] [Reference Citation Analysis]
31 Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine 2015;72:146-53. [DOI: 10.1016/j.cyto.2014.12.027] [Cited by in Crossref: 205] [Cited by in F6Publishing: 181] [Article Influence: 34.2] [Reference Citation Analysis]
32 Erciyas K, Sezer U, Ustün K, Pehlivan Y, Kisacik B, Senyurt SZ, Tarakçioğlu M, Onat AM. Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Dis 2013;19:394-400. [PMID: 22998534 DOI: 10.1111/odi.12017] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 6.2] [Reference Citation Analysis]
33 Sueki Y, Nozaki Y, Kawashima I, Yamamoto T, Nakajima K, Mitumori T, Kirito K. Anaplastic large cell lymphoma with paraneoplastic neutrophilia: an association between IL-17 elevation and aggressive disease progression. Int J Hematol 2014;99:773-6. [PMID: 24609719 DOI: 10.1007/s12185-014-1557-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
34 Singh RK, Lee KM, Vujkovic-Cvijin I, Ucmak D, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Bhutani T, Wei M, Liao W. The role of IL-17 in vitiligo: A review. Autoimmun Rev 2016;15:397-404. [PMID: 26804758 DOI: 10.1016/j.autrev.2016.01.004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
35 Boniface K. Role of Th17 cells in the pathogenesis of rheumatoid arthritis. WJR 2013;3:25. [DOI: 10.5499/wjr.v3.i3.25] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Genovese MC, Weinblatt ME, Aelion JA, Mansikka HT, Peloso PM, Chen K, Li Y, Othman AA, Khatri A, Khan NS, Padley RJ. ABT-122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin-17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate: A Randomized, Double-Blind Study. Arthritis Rheumatol 2018;70:1710-20. [PMID: 29855172 DOI: 10.1002/art.40580] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
37 Sikorska D, Rutkowski R, Łuczak J, Samborski W, Witowski J. No effect of anti-TNF-α treatment on serum IL-17 in patients with rheumatoid arthritis. Cent Eur J Immunol 2018;43:270-5. [PMID: 30588171 DOI: 10.5114/ceji.2018.80045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
38 da Rocha LF Jr, Duarte ÂL, Dantas AT, Mariz HA, Pitta Ida R, Galdino SL, Pitta MG. Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity. J Rheumatol 2012;39:1320-5. [PMID: 22589261 DOI: 10.3899/jrheum.111027] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 6.9] [Reference Citation Analysis]
39 Jawad S, Liu B, Agron E, Nussenblatt RB, Sen HN. Elevated serum levels of interleukin-17A in uveitis patients. Ocul Immunol Inflamm 2013;21:434-9. [PMID: 23957503 DOI: 10.3109/09273948.2013.815786] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
40 Moudgil KD. Interplay among cytokines and T cell subsets in the progression and control of immune-mediated diseases. Cytokine 2015;74:1-4. [PMID: 26026376 DOI: 10.1016/j.cyto.2015.05.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
41 Lin YC, Lin YC, Wu CC, Huang MY, Tsai WC, Hung CH, Kuo PL. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation. Oncotarget 2017;8:7559-71. [PMID: 27926504 DOI: 10.18632/oncotarget.13791] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
42 Pineda MA, Al-Riyami L, Harnett W, Harnett MM. Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis. Clin Exp Immunol 2014;177:13-23. [PMID: 24666108 DOI: 10.1111/cei.12252] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
43 Buondonno I, Rovera G, Sassi F, Rigoni MM, Lomater C, Parisi S, Pellerito R, Isaia GC, D'Amelio P. Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study. PLoS One 2017;12:e0178463. [PMID: 28582403 DOI: 10.1371/journal.pone.0178463] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
44 Santiago FW, Halsey ES, Siles C, Vilcarromero S, Guevara C, Silvas JA, Ramal C, Ampuero JS, Aguilar PV. Long-Term Arthralgia after Mayaro Virus Infection Correlates with Sustained Pro-inflammatory Cytokine Response. PLoS Negl Trop Dis 2015;9:e0004104. [PMID: 26496497 DOI: 10.1371/journal.pntd.0004104] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
45 Astry B, Venkatesha SH, Moudgil KD. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis. Cytokine 2015;74:54-61. [PMID: 25595306 DOI: 10.1016/j.cyto.2014.11.020] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
46 Dissanayake K, Jayasinghe C, Wanigasekara P, Sominanda A. Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A. PLoS One 2021;16:e0246111. [PMID: 33497394 DOI: 10.1371/journal.pone.0246111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Han L, Yang J, Wang X, Li D, Lv L, Li B. Th17 cells in autoimmune diseases. Front Med. 2015;9:10-19. [PMID: 25652649 DOI: 10.1007/s11684-015-0388-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
48 Luque-Campos N, Contreras-López RA, Jose Paredes-Martínez M, Torres MJ, Bahraoui S, Wei M, Espinoza F, Djouad F, Elizondo-Vega RJ, Luz-Crawford P. Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response. Front Immunol 2019;10:798. [PMID: 31040848 DOI: 10.3389/fimmu.2019.00798] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
49 Al-zifzaf DS, El Bakry SA, Mamdouh R, Shawarby LA, Ghaffar AYA, Amer HA, Alim AA, Sakr HM, Rahman RA. FoxP3+T regulatory cells in Rheumatoid arthritis and the imbalance of the Treg/TH17 cytokine axis. The Egyptian Rheumatologist 2015;37:7-15. [DOI: 10.1016/j.ejr.2014.06.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
50 Kirkham BW, Kavanaugh A, Reich K. Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. Immunology 2014;141:133-42. [PMID: 23819583 DOI: 10.1111/imm.12142] [Cited by in Crossref: 146] [Cited by in F6Publishing: 131] [Article Influence: 20.9] [Reference Citation Analysis]
51 Ahmadi H, Mahmoudi M, Gharibdoost F, Vojdanian M, Jamshidi AR, Fattahi MJ, Aghazadeh Z, Barati A, Mirshafiey A. Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritis. Inflammopharmacol 2018;26:57-65. [DOI: 10.1007/s10787-017-0410-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
52 Nakayamada S, Kubo S, Yoshikawa M, Miyazaki Y, Yunoue N, Iwata S, Miyagawa I, Hirata S, Nakano K, Saito K, Tanaka Y. Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis. Rheumatology 2018;57:164-74. [DOI: 10.1093/rheumatology/kex012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 9.5] [Reference Citation Analysis]
53 Kellner H. Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential. Ther Adv Musculoskelet Dis. 2013;5:141-152. [PMID: 23858337 DOI: 10.1177/1759720x13485328] [Cited by in Crossref: 70] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
54 Lerner UH. Role of Interleukins on Physiological and Pathological Bone Resorption and Bone Formation: Effects by Cytokines in The IL-12 and IL-17 Families, and by IL-3, IL-32 and IL-34. Encyclopedia of Bone Biology. Elsevier; 2020. pp. 88-102. [DOI: 10.1016/b978-0-12-801238-3.11554-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Taams LS, Steel KJA, Srenathan U, Burns LA, Kirkham BW. IL-17 in the immunopathogenesis of spondyloarthritis. Nat Rev Rheumatol 2018;14:453-66. [PMID: 30006601 DOI: 10.1038/s41584-018-0044-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 26.0] [Reference Citation Analysis]
56 Ebbinghaus M, Natura G, Segond von Banchet G, Hensellek S, Böttcher M, Hoffmann B, Salah FS, Gajda M, Kamradt T, Schaible HG. Interleukin-17A is involved in mechanical hyperalgesia but not in the severity of murine antigen-induced arthritis. Sci Rep 2017;7:10334. [PMID: 28871176 DOI: 10.1038/s41598-017-10509-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
57 Bochaton T, Mewton N, Thiam N, Lavocat F, Baetz D, Dufay N, Prieur C, Bonnefoy-Cudraz E, Miossec P, Ovize M. Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction. PLoS One 2017;12:e0188202. [PMID: 29166391 DOI: 10.1371/journal.pone.0188202] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
58 Zhang B, Jiang W. IL-1β, IL-17A, CRP and biologics history might serve as potential markers for clinical response to etanercept in rheumatoid arthritis patients. Inflammopharmacol 2019;27:1123-30. [DOI: 10.1007/s10787-019-00624-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
59 Noack M, Miossec P. Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol 2017;39:365-83. [DOI: 10.1007/s00281-017-0619-z] [Cited by in Crossref: 115] [Cited by in F6Publishing: 92] [Article Influence: 28.8] [Reference Citation Analysis]
60 Kan J, Mishima S, Kashiwakura J, Sasaki-Sakamoto T, Seki M, Saito S, Ra C, Tokuhashi Y, Okayama Y. Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis. Allergol Int 2016;65 Suppl:S11-6. [PMID: 27209051 DOI: 10.1016/j.alit.2016.04.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
61 Koyama K, Ohba T, Ishii K, Jung G, Haro H, Matsuda K. Development of a quick serum IL-6 measuring system in rheumatoid arthritis. Cytokine 2017;95:22-6. [PMID: 28214674 DOI: 10.1016/j.cyto.2017.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
62 Dai X, Wang LW, Jia XY, Chang Y, Wu HX, Wang C, Wei W. Paeoniflorin regulates the function of human peripheral blood mononuclear cells stimulated by rhIL-1β by up-regulating Treg expression. Immunopharmacol Immunotoxicol 2015;37:252-7. [PMID: 25986991 DOI: 10.3109/08923973.2015.1026603] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
63 Alunno A, Manetti M, Caterbi S, Ibba-Manneschi L, Bistoni O, Bartoloni E, Valentini V, Terenzi R, Gerli R. Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications. Mediators Inflamm 2015;2015:751793. [PMID: 25918479 DOI: 10.1155/2015/751793] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 8.8] [Reference Citation Analysis]
64 George G, Shyni GL, Raghu KG. Current and novel therapeutic targets in the treatment of rheumatoid arthritis. Inflammopharmacology 2020;28:1457-76. [PMID: 32948901 DOI: 10.1007/s10787-020-00757-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
65 Roodenrijs NMT, Kedves M, Hamar A, Nagy G, van Laar JM, van der Heijde D, Welsing PMJ. Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. RMD Open 2021;7:e001511. [PMID: 33514671 DOI: 10.1136/rmdopen-2020-001511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Truchetet ME, Mossalayi MD, Boniface K. IL-17 in the rheumatologist's line of sight. Biomed Res Int 2013;2013:295132. [PMID: 23984335 DOI: 10.1155/2013/295132] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
67 Terhune J, Berk E, Czerniecki BJ. Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy. Vaccines (Basel) 2013;1:527-49. [PMID: 26344346 DOI: 10.3390/vaccines1040527] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
68 Casnici C, Lattuada D, Tonna N, Crotta K, Storini C, Bianco F, Truzzi MC, Corradini C, Marelli O. Optimized "in vitro" culture conditions for human rheumatoid arthritis synovial fibroblasts. Mediators Inflamm 2014;2014:702057. [PMID: 25548436 DOI: 10.1155/2014/702057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
69 Moroz LA, Talako ТМ, Potapnev MP, Soroka NF. Dichotomy of Local Th1- and Systemic Th2/Th3-Dependent Types of Immune Response in Rheumatoid Arthritis. Bull Exp Biol Med 2019;167:69-73. [PMID: 31177446 DOI: 10.1007/s10517-019-04463-7] [Reference Citation Analysis]
70 Sorić Hosman I, Kos I, Lamot L. Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker. Front Immunol 2020;11:631299. [PMID: 33679725 DOI: 10.3389/fimmu.2020.631299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
71 Wang T, Qiao H, Zhai Z, Zhang J, Tu J, Zheng X, Qian N, Zhou H, Lu E, Tang T. Plumbagin Ameliorates Collagen-Induced Arthritis by Regulating Treg/Th17 Cell Imbalances and Suppressing Osteoclastogenesis. Front Immunol 2018;9:3102. [PMID: 30671063 DOI: 10.3389/fimmu.2018.03102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
72 Frieder J, Kivelevitch D, Haugh I, Watson I, Menter A. Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions. Clin Pharmacol Ther. 2018;103:88-101. [PMID: 28960267 DOI: 10.1002/cpt.893] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 9.8] [Reference Citation Analysis]
73 Sapir-Koren R, Livshits G. Rheumatoid arthritis onset in postmenopausal women: Does the ACPA seropositive subset result from genetic effects, estrogen deficiency, skewed profile of CD4(+) T-cells, and their interactions? Mol Cell Endocrinol 2016;431:145-63. [PMID: 27178986 DOI: 10.1016/j.mce.2016.05.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
74 Miao J, Zhang K, Lv M, Li Q, Zheng Z, Han Q, Guo N, Fan C, Zhu P. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis. Scandinavian Journal of Rheumatology 2013;43:194-201. [DOI: 10.3109/03009742.2013.846407] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
75 van der Velden D, Lagraauw HM, Wezel A, Launay P, Kuiper J, Huizinga TW, Toes RE, Bot I, Stoop JN. Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile. Arthritis Res Ther 2016;18:138. [PMID: 27296719 DOI: 10.1186/s13075-016-1036-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
76 Miyamoto Y, Uga H, Tanaka S, Kadowaki M, Ikeda M, Saegusa J, Morinobu A, Kumagai S, Kurata H. Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints. Mol Immunol 2013;54:199-207. [PMID: 23287598 DOI: 10.1016/j.molimm.2012.11.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
77 Friday SC, Fox DA. Phospholipase D enzymes facilitate IL-17- and TNFα-induced expression of proinflammatory genes in rheumatoid arthritis synovial fibroblasts (RASF). Immunology Letters 2016;174:9-18. [DOI: 10.1016/j.imlet.2016.04.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
78 Xie Q, Wang SC, Li J. IL-17: a potential therapeutic target for rheumatoid arthritis? Clin Rheumatol 2012;31:1145-6. [PMID: 22627755 DOI: 10.1007/s10067-012-2004-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
79 Ni M, Wei W, Wang Y, Zhang N, Ding H, Shen C, Zheng F. Serum levels of calreticulin in correlation with disease activity in patients with rheumatoid arthritis. J Clin Immunol 2013;33:947-53. [PMID: 23532497 DOI: 10.1007/s10875-013-9885-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
80 Noack M, Beringer A, Miossec P. Additive or Synergistic Interactions Between IL-17A or IL-17F and TNF or IL-1β Depend on the Cell Type. Front Immunol 2019;10:1726. [PMID: 31396230 DOI: 10.3389/fimmu.2019.01726] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
81 Genovese MC, Durez P, Richards HB, Supronik J, Dokoupilova E, Aelion JA, Lee SH, Codding CE, Kellner H, Ikawa T. One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study. J Rheumatol. 2014;41:414-421. [PMID: 24429175 DOI: 10.3899/jrheum.130637] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 10.4] [Reference Citation Analysis]
82 de Albuquerque R, Komsi E, Starskaia I, Ullah U, Lahesmaa R. The role of Interleukin-32 in autoimmunity. Scand J Immunol 2021;93:e13012. [PMID: 33336406 DOI: 10.1111/sji.13012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Jain M, Attur M, Furer V, Todd J, Ramirez R, Lock M, Lu QA, Abramson SB, Greenberg JD. Increased plasma IL-17F levels in rheumatoid arthritis patients are responsive to methotrexate, anti-TNF, and T cell costimulatory modulation. Inflammation 2015;38:180-6. [PMID: 25240765 DOI: 10.1007/s10753-014-0020-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
84 Elhewala AEI, Soliman SG, Labeeb AA, Mousa WA, Salah D. Interleukin-17 level in rheumatoid arthritis patients and its relation to disease activity: a clinical and ultrasound study. Egypt Rheumatol Rehabil 2015;42:183-7. [DOI: 10.4103/1110-161x.168164] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
85 Beringer A, Noack M, Miossec P. IL-17 in Chronic Inflammation: From Discovery to Targeting. Trends Mol Med. 2016;22:230-241. [PMID: 26837266 DOI: 10.1016/j.molmed.2016.01.001] [Cited by in Crossref: 216] [Cited by in F6Publishing: 196] [Article Influence: 43.2] [Reference Citation Analysis]